Forte Biosciences Cash Flow Statement (2016-2026) | FBRX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-8.73M-3.92M-2.82M-3.24M-3.52M-5.00M-6.92M-9.12M-10.22M-6.41M-7.83M-12.85M-8.66M-7.43M-15.66M-24.61M-35.79M-24.61M-22.14M-23.33M
Depreciation and Depletion (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.02M0.02M
Share-based Compensation (Quarter)
1.47M1.24M0.16M1.19M0.91M0.86M0.88M0.85M0.77M0.78M0.81M0.80M0.79M0.70M1.62M1.50M1.48M1.66M3.18M47.80M
Gains from Investment Securities (Quarter)
Cash from Operations (Quarter)
-5.13M-3.58M-1.98M-1.38M-1.94M-2.89M-5.20M-5.47M-9.06M-8.97M-6.67M-5.94M-8.13M-10.01M-10.36M-10.06M-14.00M-16.48M-18.80M-22.70M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.01M0.01M-0.01M0.16M0.24M0.01M-0.01M0.01M1.04M
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.02M0.02M
Change in Working Capital
Change in Account Payables (Quarter)
1.34M-1.38M-0.37M0.09M0.47M0.02M0.19M1.66M2.28M-3.87M0.26M3.59M-0.12M-0.71M0.58M-0.09M0.56M4.50M3.10M0.39M
Change in Accured Expenses (Quarter)
-0.58M-0.60M-0.13M0.14M0.29M0.92M0.39M0.85M-1.18M0.12M-0.59M2.19M-0.42M-1.07M1.69M-0.18M3.63M3.26M0.44M-4.92M
Other Working Capital Changes (Quarter)
-0.32M-0.50M-0.04M-0.24M0.20M-0.18M-0.09M-0.08M0.87M0.15M-0.28M0.02M0.01M1.62M-1.64M0.05M2.00M2.17M3.20M-1.70M
Investing Activities
Capital Expenditures (Quarter)
0.04M0.02M0.01M0.03M0.06M0.06M
Sales of Property, Plant and Equipment (Quarter)
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)
0.00M36.35M
Cash from Investing Activities (Quarter)
10.03M-0.02M-0.01M-35.99M36.29M-0.06M-147.84M
Financing Activities
Other financing activities (Quarter)
0.02M0.04M0.05M0.11M0.26M0.01M-0.01M1.12M0.01M-0.01M0.02M0.10M22.40M
Cash from Financing Activities (Quarter)
-0.00M-0.04M-0.03M-0.11M7.44M-0.06M0.01M-0.02M24.78M-0.07M-0.01M-0.01M-0.00M51.88M-2.32M70.35M1.32M0.01M0.07M161.95M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
25.00M7.70M7.70M0.01M24.79M0.01M-73.22M
Additional items
Change in Cash (Quarter)
-5.13M-3.62M-2.01M-1.49M5.50M-2.95M-5.20M-15.46M25.75M-9.06M-6.68M-5.95M-8.13M5.88M23.61M60.29M-12.73M-16.46M-18.73M-8.59M
Free Cash Flow (Quarter)
-5.13M-3.58M-1.98M-1.38M-1.94M-2.89M-5.20M-5.47M-9.10M-8.99M-6.67M-5.94M-8.13M-10.04M-10.42M-10.06M-14.05M-16.48M-18.80M-22.70M
Net Cash Flow (Quarter)
-5.13M-3.62M-2.01M-1.49M5.50M-2.95M-5.20M-5.50M25.75M-9.06M-6.68M-5.95M-8.13M5.88M23.61M60.29M-12.73M-16.48M-18.73M-8.59M